Description: Panelists lead participants in a discussion of recent experiences and current issues regarding the valuation of medical and dental insurance and managed care products. Topics include ASOP 22 [asset adequacy analysis for statements of actuarial opinion] and ASOP 41 [communication]. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 102

Description: Panelists discuss consumer-driven health plans [CDHPs] being implemented in combination with a variety of financial mechanisms, including health savings accounts [HSAs], health reimbursement accounts [HRAs] and flexible spending accounts [FSAs]. From Record of the Society of Actuaries, Vol. 31, No. 2, Session 104

Description: Panelists discuss changes to the Medicare program being implemented by the Medicare Modernization Act. Topics include Medicare Advantage and Part D bidding and actuarial equivalence. From the Record of the Society of Actuaries, Vol. 30, No. 3, Session 101

Description: Responds to questions received during the webcast with regards to modeling long term medical trends for valuation purposes. Questions cover testing the model against publicly traded companies, the calculation of growth rate in the model, the income multiplier as the population ages, model relevance to Canada, factoring in of extra disease burdens, exclusion of aging in the model, and the effect of the globalization of health care.

Description: This discussion on reinsurance looks at criteria which applies in setting the acceptance and retention limits of a smaller company, if its advantageous to divide risks between two or more reinsurers, and what reinsurance a small company needs on group insurance or on individual accident and sickness insurance.

Description: Presented at May 1996 Spring Meeting. This session analyzes the factors that influence the mortality differences between countries and between population and insured-lives mortality.

Description: The focus of the webcast on Modeling Long–Term Medical Trends for Valuation Purposes was a discussion of the underlying methodology of the model, a walk through of the actual model, and a review of the considerations for its practical usage by actuaries. The running time of this video is 1 hour and 3 minutes. It is a presentation of slides without audio.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 Discussion of financial modeling considerations including: • Model platforms • Model structure • Static and dynamic model validation techniques • Data integrity

Description: From an interactive forum session at the 2001 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, November 29-30, 2001 Discussion of the major financial reporting issues and concerns of senior actuaries in life insurance companies. Discussion focused cash flow testing methods and interpretation of results.

Description: Presented at October 2001 Annual Meeting. Panelists provide insight into the factors driving the cost increase of prescription drugs and how these factors are being addressed. Strategies include drug utilization review, manufacturer contracting, benefit design, formularies, pharmaceutical pricing, therapeutic substitution, physical education, and introduction of new pharmaceuticals. Also discussed are pharmacoeconomic benefit considerations when studying integrated medical and pharmacy expenses.